Breakthrough T1D Mourns the Loss of Stacey Anderson, M.D.
Breakthrough T1D is deeply saddened at the passing of Stacey Anderson, M.D. Dr. Anderson was a tireless champion for the type 1 diabetes (T1D) community, a brilliant researcher, dedicated physician, and longtime Breakthrough T1D partner, grantee, reviewer, and friend. “Dr. Stacey Anderson was a tremendous diabetes champion and she will be terribly missed,” said Breakthrough […]
EASD Conference Will Bring Together—Virtually—Top Minds in Diabetes Research
Leading researchers from around the world will gather for the annual meeting of the European Association for the Study of Diabetes (EASD).
It’s Less than Two Months Away!
From T1Day (wear blue!) to social media storytelling and celebrity appearances, Breakthrough T1D has a bunch of exciting plans that you won’t want to miss out on!
Year-end gifts provide vital support
Together with our supporters, we have played a key role in the discovery and availability of nearly every major T1D advance and we can’t stop now. Future breakthroughs start with us. We know many of you will soon contemplate your year-end giving and will want to make the most of your charitable dollars. Fortunately, the […]
FDA Approves 7-day Infusion Set
Medtronic’s Extended Wear Infusion Set (EWIS) is the first infusion set approved for 7 days, a significantly longer duration; Currently, no other infusion set is approved for more than 3 days.
Remembering a Champion, a Philanthropist, a Friend
John J. McDonough was a self-made man with a successful career in business and finance. But to us, he will be remembered for his service to Breakthrough T1D and his perseverance in moving life-changing research forward for the many people living with type 1 diabetes (T1D) today. John served on our International Board of Directors […]
Game Over, T1D! Fundraiser Brings Video Game Community Together in Support of Breakthrough T1D
From August 13–22, Breakthrough T1D Game2Give held Game Over, T1D, a livestream fundraising event that raised over $60,000 for type 1 diabetes (T1D) research.
Vertex Pharmaceuticals Investigating Cell Therapy for Type 1 Diabetes
Vertex is currently enrolling for a clinical trial evaluating their stem cell derived islet cell infusion therapy, VX-880.
Back to School with Diabetes Amidst the COVID-19 Variants
Kids with diabetes need to get back to school, but how can we best keep them safe? Experts weigh in.
Breakthrough T1D & NIH Workshop at the Intersection of Immunology and Bioengineering
Breakthrough T1D and NIH bring together top scientists and engineers to strategize on how to allow implanted beta cells to thrive.
